论文部分内容阅读
目的:探讨子宫内膜异位症腹腔镜术后配合使用孕三烯酮、米非司酮及中药治疗的疗效。方法:回顾2005年1月～2007年1月199例卵巢子宫内膜异位囊肿经腹腔镜手术后患者随机分为4组:子宫内膜异位症腹腔镜术后配合使用孕三烯酮、米非司酮及中药治疗与未用药组的疗效比较,随访1年,比较4组疗效及不良反应。结果:子宫内膜异位症腹腔镜术后配合使用孕三烯酮、米非司酮、中药治疗之间的疗效差异无显著性,而未用药组的疗效与前3组的疗效相比差异有显著性。结论:子宫内膜异位症腹腔镜术后加用药物是必要的,术后辅以孕三烯酮、米非司酮、中药治疗能有效地控制临床症状,延迟病灶复发时间,降低复发率,近期疗效较满意,远期疗效需要进一步观察。
Objective: To investigate the efficacy of gestrinone, mifepristone and traditional Chinese medicine in patients with endometriosis after laparoscopic surgery. Methods: A retrospective study of 199 cases of ovarian endometriosis cyst after laparoscopic surgery from January 2005 to January 2007 were randomly divided into 4 groups: endometriosis combined with gestrinone after laparoscopic surgery, Mifepristone and traditional Chinese medicine treatment and non-treatment group compared efficacy, follow-up of 1 year, the efficacy of four groups and adverse reactions were compared. Results: There was no significant difference in efficacy between gestrinone and mifepristone treated with laparoscopy and endometriosis in patients with endometriosis, while those in the untreated group were significantly different from those in the first three groups Significant. Conclusion: It is necessary to add drugs after laparoscopic surgery for endometriosis. Supplementation with gestrinone, mifepristone and traditional Chinese medicine can effectively control clinical symptoms, delay the time of relapse and reduce the recurrence rate , The recent efficacy is more satisfactory, long-term efficacy needs further observation.